According to European legislation, CBD cannot be marketed as a food supplement and is not considered fit for human consumption.
In countries such as the United States, Canada, United Kingdom or Switzerland, the legislation allows taking CBD oil sublingually or as a food supplement. Users and brands in these countries move in a different legal framework although the products are the same.
Recommendations for use at Hannapy
Hannapy is a Spanish-based company, so we are obliged to warn that the use of CBD should only be topical on the skin, as a decorative product or as a collector's item.
Legal use of CBD
To enjoy the effects of cbd oil, we must put the necessary drops on the affected area. In case of looking for a relaxing effect and / or sleep aid, we must put the necessary drops on the chest and massage gently.
To enjoy the effects of cbd resins and flowers, they should be opened from their original packaging and let their aromas be detectable by the olfactory sense. Their potentially sensation-generating aromas will act on the endocannabinoid system.
We warn that some brands may not comply with the Spanish legislation on the use of CBD in the instructions for use in their original packaging.
Confusion as to the indications for use arises from legislative differences between countries. Many of these brands can explain both topical and human consumption uses of cbd.
The Spanish customer must understand his responsibility as a consumer within the Spanish legal framework.
Hannapy is not responsible for the use outside the current Spanish legal framework of any product promoted on Hannapy's websites or platforms.
About hemp cultivation
At the level of cultivation and CBD flowers, by Royal Decree 1729/1999, of November 12, 1999, the Spanish government has authorized the cultivation of 25 varieties of industrial hemp. For the cultivation of hemp to be legal in our country, the seeds must be certified by the European Union. The European laws that collect the legislation on the cultivation of CBD hemp are the European Decree n. 639-2014; European Regulation n. 1307/2013.
Conclusion
By way of conclusion, the cultivation and commercialization of CBD products are totally legal in europe, as long as their object of use remains within the conditions defined in the laws previously commented in this same text.
Any product derived from the cannabis plant, marketed in Europe, must come from industrial hemp and its THC content must be less than 0.2%, ensuring that in no case the product will produce psychotropic effects.
The WHO (World Health Organization) has officially confirmed that cannabidiol is a safe, non-addictive product that does not generate serious side effects.